Literature DB >> 22728706

Stemness gene expression profile analysis in human umbilical cord mesenchymal stem cells.

Ming-Yao Meng1, Wei Pang, Li-Hong Jiang, Yun-Hong Liu, Chuan-Yu Wei, Yan-Hua Xie, Hai-Dong Yu, Zong-Liu Hou.   

Abstract

Umbilical cord mesenchymal stem cells (UC-MSCs) have several advantages for clinical therapy: the material is easily obtainable, the donation procedure is painless and there is low risk of viral contamination. UC-MSCs play important roles in tissue regeneration, tissue damage repair, autoimmune disease and graft-versus-host disease. In this study, we investigated the normal mRNA expression profile of UC-MSCs, and analyzed the candidate proteins responsible for the signaling pathway that may affect the differentiation characteristics of UC-MSCs. UC-MSCs were isolated by mincing UC samples into fragments and placing them in growth medium in a six-well plate. The immunophenotype characteristics and multilineage differentiation potential of the UC-MSCs were measured by flow cytometry and immunohistochemical assays. In addition, the pathway-focused gene expression profile of UC-MSCs was compared with those of normal or tumorous cells by realtime quantitative polymerase chain reaction. We successfully isolated and cultured UC-MSCs and analyzed the appropriate surface markers and their capacity for osteogenic, adipogenic and neural differentiation. In total, 168 genes focusing on signal pathways were examined. We found that the expression levels of some genes were much higher or lower than those of control cells, either normal or tumorous. UC-MSCs exhibit a unique mRNA expression profile of pathway-focused genes, especially some stemness genes, which warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728706     DOI: 10.1258/ebm.2012.011429

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  5 in total

1.  MSC-released TGF-β regulate α-SMA expression of myofibroblast during wound healing.

Authors:  Agung Putra; Iffan Alif; Nurfitriani Hamra; Octyana Santosa; Azizah Retno Kustiyah; Adi Muradi Muhar; Kiki Lukman
Journal:  J Stem Cells Regen Med       Date:  2020-12-11

2.  Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.

Authors:  Zong-liu Hou; Ying Liu; Xi-Hong Mao; Chuan-yu Wei; Ming-yao Meng; Yun-hong Liu; Zara Zhuyun Yang; Hongmei Zhu; Martin Short; Claude Bernard; Zhi-cheng Xiao
Journal:  Cell Adh Migr       Date:  2013-10-30       Impact factor: 3.405

3.  Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.

Authors:  Lei Pu; Mingyao Meng; Jian Wu; Jing Zhang; Zongliu Hou; Hui Gao; Hui Xu; Boyu Liu; Weiwei Tang; Lihong Jiang; Yaxiong Li
Journal:  Stem Cell Res Ther       Date:  2017-03-21       Impact factor: 6.832

4.  Cross-Tissue Characterization of Heterogeneities of Mesenchymal Stem Cells and Their Differentiation Potentials.

Authors:  Wenhong Hou; Li Duan; Changyuan Huang; Xingfu Li; Xiao Xu; Pengfei Qin; Ni Hong; Daping Wang; Wenfei Jin
Journal:  Front Cell Dev Biol       Date:  2021-12-17

5.  Umbilical Cord Mesenchymal Stromal Cell-Derived Exosomes Rescue the Loss of Outer Hair Cells and Repair Cochlear Damage in Cisplatin-Injected Mice.

Authors:  Stella Chin-Shaw Tsai; Kuender D Yang; Kuang-Hsi Chang; Frank Cheau-Feng Lin; Ruey-Hwang Chou; Min-Chih Li; Ching-Chang Cheng; Chien-Yu Kao; Chie-Pein Chen; Hung-Ching Lin; Yi-Chao Hsu
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.